"False"
Skip to content
umu.se
For students
Library
For staff
Login
Students
All students must change their password since 7 May.
Edit
Edit content at umu.se
Svensk webbplats
Search
Menu
X close menu
Menu
Search
Search within:
Search within:
All
Education
Research
Staff
Student web
News
Other search services
Find courses and programmes
Library search tool
Search the legal framework
Main menu hidden.
Login
Students
All students must change their password since 7 May.
Edit
Edit content at umu.se
Svenska
Anders Själander
Research qualifications:
Docent
Educational qualifications:
Distinguished university teacher
Contact
E-mail
anders.sjalander@umu.se
Phone
+46 90 786 53 82
Works at
Affiliation
Professor, senior consultant (attending) physician at
Department of Public Health and Clinical Medicine
Location
Byggnad 1A, plan 4, målpunkt B41, Norrlands universitetssjukhus
Umeå universitet, 901 85 Umeå
Publications
Publications
Research
Research
2024
Thromboembolic events, major bleeding and mortality in essential thrombocythaemia and polycythaemia vera: a matched nationwide population-based study
British Journal of Haematology
, John Wiley & Sons 2024, Vol. 204, (5) : 1740-1751
Enblom-Larsson, Anneli; Renlund, Henrik; Andréasson, Björn; et al.
2024
Improved adherence to statin treatment and differences in results between men and women after pictorial risk communication: a sub-study of the VIPVIZA RCT
European Journal of Clinical Pharmacology
, Springer 2024, Vol. 80, (8) : 1209-1218
Holmberg, Henrik; Glader, Eva-Lotta; Näslund, Ulf; et al.
2024
Rätt nivå på kunskapsprovet, men regionerna skulle kunna göra mer
Läkartidningen
Hultin, Magnus; Själander, Anders
2024
Prevalence of atrial fibrillation and reasons for undertreatment with oral anticoagulants
Journal of Thrombosis and Thrombolysis
, Springer Nature 2024, Vol. 57 : 101-106
Lilja, Johan; Själander, Anders; Själander, Sara
2024
ABO blood groups, RhD factor and their association with subclinical atherosclerosis assessed by carotid ultrasonography
Journal of Clinical Medicine
, MDPI 2024, Vol. 13, (5)
Mickelsson, Malin; Ekblom, Kim; Stefansson, Kristina; et al.
2024
Risk factors for major bleeding in patients with atrial fibrillation and CKD G3–G5D on oral anticoagulants
Clinical Kidney Journal
, Oxford University Press 2024, Vol. 17, (8)
Welander, Frida; Renlund, Henrik; Själander, Anders
2023
The impact of Covid-19 in patients with chronic myeloid leukemia: a nationwide population-based study
Leukemia
, Springer Nature 2023, Vol. 37 : 1156-1159
Dahlén, Torsten; Flygt, Hjalmar; Lübking, Anna; et al.
2023
Erythrocytosis, thrombocytosis, and rate of recurrent thromboembolic event: a population based cohort study
European Journal of Haematology
, John Wiley & Sons 2023, Vol. 110, (6) : 608-617
Enblom, Anneli; Andréasson, Björn; Holmberg, Henrik; et al.
2023
Entrustable professional activities (EPAs) for undergraduate medical education: development and exploration of social validity
BMC Medical Education
, BioMed Central (BMC) 2023, Vol. 23, (1)
Gummesson, Christina; Alm, Stina; Cederborg, Anna; et al.
2023
Direct oral anticoagulants: patient reported adherence and minor bleedings
Journal of Thrombosis and Thrombolysis
, Springer 2023, Vol. 56, (1) : 55-64
Hayat, Amina; Själander, Anders; Wallvik, Jonas
2023
Reduced dose direct oral anticoagulants compared with warfarin with high time in therapeutic range in nonvalvular atrial fibrillation
Journal of Thrombosis and Thrombolysis
, Springer Nature 2023, Vol. 55, (3) : 415-425
Jansson, Martin; Själander, Sara; Sjögren, Vilhelm; et al.
2023
Direct oral anticoagulants versus warfarin in patients with non-valvular atrial fibrillation and CKD G3-G5D
Clinical Kidney Journal
, Oxford University Press 2023, Vol. 16, (5) : 835-844
Welander, Frida; Renlund, Henrik; Dimény, Emöke; et al.
2022
Adverse outcomes in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: Follow-up of patients diagnosed 2002–2017 in a complete coverage and nationwide agnostic register study
American Journal of Hematology
, John Wiley & Sons 2022, Vol. 97, (4) : 421-430
Dahlén, Torsten; Edgren, Gustaf; Ljungman, Per; et al.
2022
Time to initiation of lipid-lowering drugs for subclinical atherosclerosis: sub-study of VIPVIZA randomized controlled trial, with single-arm cross-over
European Heart Journal Open
, Oxford University Press 2022, Vol. 2, (1)
Holmberg, Henrik; Sjölander, Maria; Glader, Eva-Lotta; et al.
2022
Fem år med kunskapsprovet har gett oss 503 kompetenta kollegor
Läkartidningen
Hultin, Magnus; Själander, Anders
2022
Celiac disease and upper secondary school achievement in Sweden: A retrospective cohort study
BMC Pediatrics
, BioMed Central (BMC) 2022, Vol. 22, (1)
Johansson, Katarina; Norström, Fredrik; Green, Peter H R; et al.
2022
Incidence and risk factors of venous thromboembolism in men and women
Thrombosis Research
, Vol. 214 : 82-86
Lind, Marcus; Johansson, Magdalena; Själander, Anders; et al.
2022
Efficacy and safety of warfarin in patients with non-valvular atrial fibrillation and CKD G3-G5D
Clinical Kidney Journal
, Oxford University Press 2022, Vol. 15, (6) : 1169-1178
Welander, Frida; Renlund, Henrik; Dimény, Emöke; et al.
2021
Prevalence of Subclinical Coronary Artery Atherosclerosis in the General Population
Circulation
, American Heart Association 2021, Vol. 144, (12) : 916-929
Bergström, Göran; Persson, Margaretha; Adiels, Martin; et al.
2021
Successful tyrosine kinase inhibitor discontinuation outside clinical trials: data from the population-based Swedish chronic myeloid leukaemia registry
British Journal of Haematology
, John Wiley & Sons 2021, Vol. 193, (5) : 915-921
Flygt, Hjalmar; Sandin, Fredrik; Dahlén, Torsten; et al.
2021
Molecular status 36 months after TKI discontinuation in CML is highly predictive for subsequent loss of MMR: final report from AFTER-SKI
Leukemia
, Springer Nature 2021, Vol. 35, (8) : 2416-2418
Richter, Johan; Lübking, Anna; Söderlund, Stina; et al.
2021
Bleeding risk in patients with venous thromboembolic events treated with new oral anticoagulants
Journal of Thrombosis and Thrombolysis
, Springer 2021, Vol. 52, (1) : 315-323
Wange, Niklas; Renlund, Henrik; Själander, Anders
2021
Prophylactic anticoagulants to prevent venous thromboembolism in patients with nephrotic syndrome: A retrospective observational study
PLOS ONE
, Public Library of Science (PLoS) 2021, Vol. 16, (7)
Welander, Frida; Holmberg, Henrik; Dimény, Emöke; et al.
2020
Inviting the Test Takers to Challenge the Items Might Drive Quality Improvement in National Licensing Tests for International Medical Graduates
EBMA 2020: Past, Present and Future Assessment in Medical Education
Hultin, Magnus; Edin, Benoni B.; Själander, Anders
2020
Direct comparisons of effectiveness and safety of treatment with Apixaban, Dabigatran and Rivaroxaban in atrial fibrillation
Thrombosis Research
, PERGAMON-ELSEVIER SCIENCE LTD 2020, Vol. 185 : 135-141
Jansson, Martin; Själander, Sara; Sjögren, Vilhelm; et al.
2020
Increased Risk of Chronic Myeloid Leukemia Following Gastric Conditions Indicating Helicobacter pylori Infection: A Case-Control Study
Cancer Epidemiology, Biomarkers and Prevention
, Philadelphia: American Association of Cancer Research 2020, Vol. 29, (1) : 151-156
Larfors, Gunnar; Richter, Johan; Själander, Anders; et al.
2019
Predictors for INR-control in a well-managed warfarin treatment setting
Journal of Thrombosis and Thrombolysis
, Springer 2019, Vol. 47, (2) : 227-232
Björck, Fredrik; Kadhim, Hayder; Själander, Anders
2019
Kunskapsprovet säkrar kompetens och förmåga
Dagens Medicin
Hultin, Magnus; Själander, Anders; Hultberg, Pernilla; et al.
2018
Two Years Experiences of a new Swedish National Proficiency Test for Doctors of Medicine.
undee: 2018
Hultin, Magnus; Edin, Benoni B.; Själander, Anders
2018
Sänkta krav på utländska läkare vore förödande
Dagens Samhälle
, (4 dec)
Hultin, Magnus; Själander, Anders; Edin, Benoni; et al.
2018
NOAK vid venös tromboembolism samt hantering av blödningar
Läkartidningen
, Sveriges läkarförbund 2018, Vol. 115, (49-50)
Själander, Sara; Själander, Anders
2018
Dabigatran, rivaroxaban and apixaban vs. high TTR warfarin in atrial fibrillation
Thrombosis Research
, Elsevier 2018, Vol. 167 : 113-118
Själander, Sara; Sjögren, Vilhelm; Renlund, Henrik; et al.
2018
Atherothrombosis and Thromboembolism: Position Paper from the Second Maastricht Consensus Conference on Thrombosis
Thrombosis and Haemostasis
, SCHATTAUER GMBH-VERLAG MEDIZIN NATURWISSENSCHAFTEN 2018, Vol. 118, (2) : 229-250
Spronk, H. M. H.; Padro, T.; Siland, J. E.; et al.
2018
Triple therapy after PCI - Warfarin treatment quality and bleeding risk
PLOS ONE
, Public Library Science 2018, Vol. 13, (12)
Wadell, Daniel; Jensen, Jens; Englund, Erling; et al.
2017
Warfarin treatment quality and prognosis in patients with mechanical heart valve prosthesis
Heart
, BMJ Publishing Group Ltd 2017, Vol. 103, (3) : 198-203
Grzymala-Lubanski, Bartosz; Svensson, Peter J.; Renlund, Henrik; et al.
2017
Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia
Leukemia
, Vol. 31, (5) : 1108-1116
Ilander, M; Olsson-Strömberg, U; Schlums, H; et al.
2017
The impact of socio-economic factors on treatment choice and mortality in chronic myeloid leukaemia
European Journal of Haematology
, Vol. 98, (4) : 398-406
Larfors, Gunnar; Sandin, Fredrik; Richter, Johan; et al.
2017
Ischemic stroke rates decline in patients with atrial fibrillation as anticoagulants uptake improves: A Swedish cohort study
Thrombosis Research
, PERGAMON-ELSEVIER SCIENCE LTD 2017, Vol. 158 : 44-48
Mochalina, Natalia; Isma, Nazim; Svensson, Peter J.; et al.
2017
Bleeding complications and mortality in warfarin-treated VTE patients, dependence of INR variability and iTTR
Thrombosis and Haemostasis
, Vol. 117, (1) : 27-32
Sandén, Per; Renlund, Henrik; Svensson, Peter J.; et al.
2017
Venous thromboembolism and cancer risk
Journal of Thrombosis and Thrombolysis
, Vol. 43, (1) : 68-73
Sandén, Per; Svensson, Peter J; Själander, Anders
2017
Assessment of use vs discontinuation of oral anticoagulation after pulmonary vein isolation in patients with atrial fibrillation
JAMA cardiology
, American Medical Association 2017, Vol. 2, (2) : 146-152
Själander, Sara; Holmqvist, Fredrik; Smith, J Gustav; et al.
2017
Non-vitamin K oral anticoagulants are non-inferior for stroke prevention but cause fewer major bleedings than well-managed warfarin: a retrospective register study
PLOS ONE
, PUBLIC LIBRARY SCIENCE 2017, Vol. 12, (7)
Sjögren, Vilhelm; Byström, Björn; Renlund, Henrik; et al.
2017
Safety and Efficacy of Bridging With Low-Molecular-Weight Heparin During Temporary Interruptions of Warfarin: A Register-Based Cohort Study
Clinical and applied thrombosis/hemostasis
, Sage Publications 2017, Vol. 23, (8) : 961-966
Sjögren, Vilhelm; Grzymala-Lubanski, Bartosz; Renlund, Henrik; et al.
2017
Advanced phase chronic myeloid leukaemia (CML) in the tyrosine kinase inhibitor era: a report from the Swedish CML register
European Journal of Haematology
, Vol. 98, (1) : 57-66
Söderlund, Stina; Dahlén, Torsten; Sandin, Fredrik; et al.
2016
Warfarin persistence among atrial fibrillation patients – why is treatment ended?
Cardiovascular Therapeutics
, Vol. 34, (6) : 468-474
Björck, Fredrik; Ek, Agnes; Johansson, Lars; et al.
2016
Outcomes in a Warfarin-Treated Population With Atrial Fibrillation
JAMA cardiology
, American Medical Association 2016, Vol. 1, (2) : 172-180
Björck, Fredrik; Renlund, Henrik; Lip, Gregory Y. H.; et al.
2016
Cardiovascular Events Associated With Use of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Population-Based Cohort Study
Annals of Internal Medicine
, Karolinska Univ Hosp, Stockholm, Sweden. Karolinska Inst, Stockholm, Sweden. Reg Canc Ctr, Uppsala, Sweden. Univ Uppsala Hosp, Uppsala, Sweden. Umea Univ, Umea, Sweden. Skane Univ Hosp, Lund, Sweden. [Dahlen, Torsten; Bjorkholm, Magnus; Ohm, Lotta; Stenke, Leif] Karolinska Univ Hosp Solna, Div matol, Dept Med, SE-17176 Stockholm, Sweden. [Edgren, Gustaf; Lambe, Mats] Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, eden. [Hoglund, Martin; Olsson-Stromberg, Ulla] Univ Hosp, Dept Med Sci, SE-75185 Uppsala, Sweden. [Hoglund, Martin; Olsson-Stromberg, Ulla] Univ Hosp, Div Hematol, SE-75185 Uppsala, Sweden. [Sandin, Fredrik] Uppsala Univ Hosp, Reg Canc Ctr, SE-75185 Uppsala, Sweden. [Sjalander, Anders] Umea Univ, Dept Publ Hlth & Clin Med, SE-90185 Umea, Sweden. [Richter, Johan] Skane Univ Hosp, Dept Hematol & Vasc Disorders, SE-22241 Lund, Sweden. [Back, Magnus] Karolinska Univ Hosp, Dept Cardiol, SE-17176 Stockholm, Sweden.: 2016, Vol. 165, (3) : 161-166
Dahlen, Torsten; Edgren, Gustaf; Lambe, Mats; et al.
2016
Increased prevalence of prior malignancies and autoimmune diseases in patients diagnosed with chronic myeloid leukemia
Leukemia
, Vol. 30, (7) : 1562-1567
Gunnarsson, Niklas; Höglund, M.; Stenke, L.; et al.
2016
Population-based assessment of chronic myeloid leukemia in Sweden: striking increase in survival and prevalence
European Journal of Haematology
, Vol. 97, (4) : 387-392
Gunnarsson, Niklas; Sandin, Fredrik; Höglund, Martin; et al.
2016
Incidence and risk factors for thromboembolism and major bleeding in patients with mechanical valve prosthesis: a nationwide population-based study
American Heart Journal
, Vol. 181 : 1-9
Labaf, Ashkan; Svensson, Peter J; Renlund, Henrik; et al.
View publications in DiVA
Research projects
29 April 2013 until 31 December 2027
VIPVIZA
+ Show more
- Show less